CMB International: Upgraded the target price of WuXi Bio to HK$ 22.88, optimistic about the company's valuation and performance repair. CMB International published a report, predicting that the US Biosafety Act will fail with high probability, which will help WuXi Bio to achieve continuous performance growth in a relatively stable business environment. With the recovery of global biomedical financing, we are optimistic about the company's valuation and performance repair. According to the report, the NDAA in FY 2025 does not include the Biosafety Act, and the legislation of the Biosafety Act failed with high probability. On December 7, the US Senate and the House Armed Services Committee announced the National Defense Authorization Act (NDAA) for fiscal year 2025, which was finally negotiated by the committees of the two houses. The Biosafety Act was not included in the amendment of NDAA in FY 2025, which means that the Biosafety Act failed to pass the legislative path of joining NDAA. The Biosafety Act can still promote separate legislation, but considering that the window of the current US Congress session is less than two weeks, the Bank believes that the success rate of separate legislation is extremely low. CMB International maintained the "Buy" rating of Yaoming Bio, and its target price rose from HK$ 13.58 to HK$ 22.88. It is estimated that the company's revenue will increase by 7.1%/12.4%/ 13.9% from 2024 to 2026, and its adjusted net profit will increase by 0.8%/11.1%/13.4% respectively.A new round of "account opening war" has come. Some banks have already arranged specific marketing tasks at the grassroots level on the day when the notice was issued. On December 12, the Ministry of Human Resources and Social Security and other five departments jointly issued the "Notice on the Full Implementation of the Individual Pension System", which pointed out the key direction for the next development of relevant financial institutions. "The Bank has arranged a business-side meeting to deploy the work after the full implementation of the personal pension business." The relevant person in charge of the retail line of the head office of a stock bank told the reporter. It is also known that some banks have already arranged specific marketing tasks at the grassroots level on the day when the Notice was issued. When the personal pension system is fully rolled out, banks, insurance and other financial institutions with exhibition industry qualifications are actively preparing for the upgrading and optimization of personal pension business. A new round of "staking the land" for banks in account opening, deposit and agency sales is about to start, and the product reserves of various financial institutions will also reach a new level. (CSI Taurus)According to sources, Keppel and Sovico Group are discussing submarine cables between Singapore and Vietnam.
IDC: The global market for sweeping robots continued to grow in the third quarter. According to IDC's Quarterly Tracking Report on the Global Smart Home Equipment Market, the third quarter of 2024, the global market for intelligent sweeping robots shipped 5.014 million units in the third quarter, up 11.1% year-on-year. Among them, the domestic market was boosted by the trade-in of old models at the end of September, with 1.321 million units shipped, up by 17% year-on-year, and the efforts of most provinces were around 20%, which significantly stimulated the shipment of high-end models, and this trend also continued to this year's "Double Eleven". The proportion of overseas sales of China manufacturers continues to increase, and the competition of high-end all-around models in European and American markets is still fierce.Guosheng Financial Holdings hit the daily limit in the afternoon and staged the "Earth Sky Board". The turnover exceeded 3.5 billion yuan, and the stock price approached an all-time high.In the communication service sector, the daily limit of Bee Assistant was higher, and the communication service sector was higher. The daily limit of Xiangjiang and Bee Assistant in the city was higher. Three-dimensional communication and Beiwei Technology were previously closed, and Runze Technology rose by more than 10%. Century Hengtong, Halo New Network, Chaoxun Communication, Guangmai Technology and Runjian shares followed suit.
CICC: It is expected that the central bank will further set up other new monetary instruments in the future. CICC said that on the basis of Politburo meeting of the Chinese Communist Party, the policy objectives and directions of the Central Economic Work Conference have been further stated. For next year's economic goals, after "maintaining stable economic growth", the meeting proposed to "maintain overall stability in employment and prices" and pointed out that "we should pay attention to target guidance and strive to achieve an optimal combination of stable growth, stable employment and reasonable price recovery". In terms of monetary policy, CICC believes that this meeting clearly pointed out that "timely RRR cuts and interest rate cuts". It is expected that in order to meet the government bond issuance, credit supply and seasonal liquidity demand, the RRR cut may be implemented before the Spring Festival, and the interest rate cut may also be gradually promoted with the Fed's interest rate cut. CICC also judged that in the past period, the central bank has established new monetary instruments such as treasury bonds trading tools, securities fund insurance company exchange facilities, and affordable housing refinancing, and its ability to play a role in the stock, bond, real estate and other markets has been strengthened, and other new instruments may be further established in the future. (SSE)CMB International: Upgraded the target price of WuXi Bio to HK$ 22.88, optimistic about the company's valuation and performance repair. CMB International published a report, predicting that the US Biosafety Act will fail with high probability, which will help WuXi Bio to achieve continuous performance growth in a relatively stable business environment. With the recovery of global biomedical financing, we are optimistic about the company's valuation and performance repair. According to the report, the NDAA in FY 2025 does not include the Biosafety Act, and the legislation of the Biosafety Act failed with high probability. On December 7, the US Senate and the House Armed Services Committee announced the National Defense Authorization Act (NDAA) for fiscal year 2025, which was finally negotiated by the committees of the two houses. The Biosafety Act was not included in the amendment of NDAA in FY 2025, which means that the Biosafety Act failed to pass the legislative path of joining NDAA. The Biosafety Act can still promote separate legislation, but considering that the window of the current US Congress session is less than two weeks, the Bank believes that the success rate of separate legislation is extremely low. CMB International maintained the "Buy" rating of Yaoming Bio, and its target price rose from HK$ 13.58 to HK$ 22.88. It is estimated that the company's revenue will increase by 7.1%/12.4%/ 13.9% from 2024 to 2026, and its adjusted net profit will increase by 0.8%/11.1%/13.4% respectively.Japan's final industrial output value in October increased by 2.8% month-on-month and 1.4% year-on-year.
Strategy guide
Strategy guide 12-14